Affymetrix to Webcast Presentation at JPMorgan Healthcare Conference SANTA CLARA, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Affymetrix, Inc. today announced that it will present at the 22nd Annual JPMorgan Healthcare Conference in San Francisco. A live transmission of the presentation will take place at 6:00 pm ET on Monday, January 12, 2004. An archived webcast will be available for 30 days. Affymetrix Founder, Chairman and Chief Executive Officer Stephen P.A. Fodor will provide an overview of the company and outline future growth opportunities. To access the live webcast or archived presentation, please go to http://www.affymetrix.com/ and click on the "Investors" link. About Affymetrix Affymetrix is a pioneer in creating breakthrough tools that are driving the genomic revolution. By applying the principles of semiconductor technology to the life sciences, Affymetrix develops and commercializes systems that enable scientists to improve the quality of life. The Company's customers include pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies, as well as academic, government, and other non-profit research institutes. Affymetrix offers an expanding portfolio of integrated products and services, including its integrated GeneChip(R) brand platform to address the growing markets focused on understanding the relationship between genes and human health. Additional information on Affymetrix may be found at http://www.affymetrix.com/. DATASOURCE: Affymetrix, Inc. CONTACT: Doug Farrell, Vice President of Investor Relations, +1-408-731-5285 Web site: http://www.affymetrix.com/

Copyright

Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Affymetrix Charts.
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Affymetrix Charts.